News
InvestorsHub on MSN48m
BiomX Shares Surge 60% Following Start of Phase 2b Trial for Cystic Fibrosis TreatmentBiomX Inc. (AMEX:PHGE) saw its stock jump 60% after announcing the commencement of patient dosing in its Phase 2b clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback